Overview

Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients

Status:
Not yet recruiting
Trial end date:
2020-11-30
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy and safety of MTX-loaded nanoparticles in three different doses to treat severe COVID-19 patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Azidus Brasil
Collaborators:
Hospital Santa Marcelina
InCor Heart Institute
Prevent Senior Institute
PREVENT SENIOR PRIVATE OPERADORA DE SAÚDE LTDA
Treatments:
Methotrexate